S.M. de Boer

712 total citations
11 papers, 527 citations indexed

About

S.M. de Boer is a scholar working on Infectious Diseases, Ecology, Evolution, Behavior and Systematics and Epidemiology. According to data from OpenAlex, S.M. de Boer has authored 11 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Ecology, Evolution, Behavior and Systematics and 3 papers in Epidemiology. Recurrent topics in S.M. de Boer's work include Viral Infections and Outbreaks Research (9 papers), Viral Infections and Vectors (8 papers) and Vector-Borne Animal Diseases (6 papers). S.M. de Boer is often cited by papers focused on Viral Infections and Outbreaks Research (9 papers), Viral Infections and Vectors (8 papers) and Vector-Borne Animal Diseases (6 papers). S.M. de Boer collaborates with scholars based in Netherlands, France and Germany. S.M. de Boer's co-authors include Jeroen Kortekaas, R.J.M. Moormann, Berend‐Jan Bosch, Peter J. M. Rottier, A.F.G. Antonis, Jet Kant, Rianka P. M. Vloet, Cornelis A. M. de Haan, Lotte Spel and Ben Peeters and has published in prestigious journals such as Science, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

S.M. de Boer

11 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.M. de Boer Netherlands 10 419 203 104 89 76 11 527
Jin Won Song South Korea 10 300 0.7× 65 0.3× 98 0.9× 91 1.0× 119 1.6× 17 466
Maria Rosenthal Germany 15 429 1.0× 83 0.4× 219 2.1× 81 0.9× 55 0.7× 24 633
Aiko Fukuma Japan 15 558 1.3× 200 1.0× 146 1.4× 88 1.0× 171 2.3× 24 678
Udo Bahr Germany 9 284 0.7× 59 0.3× 69 0.7× 71 0.8× 127 1.7× 19 508
Miao-Ruo Wang China 8 403 1.0× 92 0.5× 90 0.9× 100 1.1× 116 1.5× 9 463
Luiz Tadeu Moraes Figueiredo Brazil 12 434 1.0× 115 0.6× 181 1.7× 51 0.6× 108 1.4× 36 524
Peter Marszal Canada 12 517 1.2× 130 0.6× 125 1.2× 220 2.5× 71 0.9× 16 651
Marko Zivcec United States 15 883 2.1× 367 1.8× 386 3.7× 97 1.1× 153 2.0× 19 969
Raquel Rivas Spain 13 356 0.8× 77 0.4× 168 1.6× 164 1.8× 44 0.6× 26 486
Gunnel Lindegren Sweden 13 566 1.4× 190 0.9× 351 3.4× 44 0.5× 94 1.2× 17 664

Countries citing papers authored by S.M. de Boer

Since Specialization
Citations

This map shows the geographic impact of S.M. de Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.M. de Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.M. de Boer more than expected).

Fields of papers citing papers by S.M. de Boer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.M. de Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.M. de Boer. The network helps show where S.M. de Boer may publish in the future.

Co-authorship network of co-authors of S.M. de Boer

This figure shows the co-authorship network connecting the top 25 collaborators of S.M. de Boer. A scholar is included among the top collaborators of S.M. de Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.M. de Boer. S.M. de Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Luteijn, Rutger D., Frank Thiele, Katrin Singethan, et al.. (2020). A Broad-Spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope. Cells. 9(9). 1989–1989. 16 indexed citations
2.
Guardado‐Calvo, Pablo, Scott A. Jeffers, Marija Backović, et al.. (2017). A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion. Science. 358(6363). 663–667. 59 indexed citations
3.
Ulferts, Rachel, S.M. de Boer, Lonneke van der Linden, et al.. (2016). Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C. Antimicrobial Agents and Chemotherapy. 60(5). 2627–2638. 54 indexed citations
5.
Boer, S.M. de, Jeroen Kortekaas, Lotte Spel, et al.. (2012). Acid-Activated Structural Reorganization of the Rift Valley Fever Virus Gc Fusion Protein. Journal of Virology. 86(24). 13642–13652. 65 indexed citations
6.
Wal, F.J. van der, René P. Achterberg, S.M. de Boer, et al.. (2012). Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein. Journal of Virological Methods. 183(2). 99–105. 21 indexed citations
7.
Boer, S.M. de, Jeroen Kortekaas, Cornelis A. M. de Haan, et al.. (2012). Heparan Sulfate Facilitates Rift Valley Fever Virus Entry into the Cell. Journal of Virology. 86(24). 13767–13771. 77 indexed citations
8.
Kortekaas, Jeroen, A.F.G. Antonis, Jet Kant, et al.. (2012). Efficacy of three candidate Rift Valley fever vaccines in sheep. Vaccine. 30(23). 3423–3429. 60 indexed citations
9.
Kortekaas, Jeroen, S.M. de Boer, Jet Kant, et al.. (2010). Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine. 28(27). 4394–4401. 59 indexed citations
10.
Boer, S.M. de, Jeroen Kortekaas, A.F.G. Antonis, et al.. (2010). Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge. Vaccine. 28(11). 2330–2339. 58 indexed citations
11.
Kortekaas, Jeroen, S.M. de Boer, K. Weerdmeester, et al.. (2010). Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus. Vaccine. 28(11). 2271–2276. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026